We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+13.78%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.8B
AUM Growth
+$1.68B
(+11%)
Cap. Flow
-$601M
Cap. Flow
% of AUM
-3.58%
Top 10 Holdings %
Top 10 Hldgs %
18.74%
Holding
1,305
New
129
Increased
549
Reduced
440
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$101M |
| 2 |
Texas Instruments
TXN
|
+$84.9M |
| 3 |
TSMC
TSM
|
+$77.7M |
| 4 |
Cisco
CSCO
|
+$59.3M |
| 5 |
NextEra Energy
NEE
|
+$49.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$840M |
| 2 |
Procter & Gamble
PG
|
+$95.7M |
| 3 |
Alibaba
BABA
|
+$57.3M |
| 4 |
Merck
MRK
|
+$49.9M |
| 5 |
Target
TGT
|
+$40.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.67% |
| 2 | Healthcare | 16.73% |
| 3 | Financials | 14.72% |
| 4 | Communication Services | 9.74% |
| 5 | Industrials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AHT
951
Ashford Hospitality Trust
AHT
$20.7M
| $397K | ﹤0.01% |
+61
| New | +$294K |
|
952
Enanta Pharmaceuticals
ENTA
$400M
| $396K | ﹤0.01% |
4,400
+850
| +24% | +$76.2K |
|
953
Chord Energy
CHRD
$7.63B
| $390K | ﹤0.01% |
29,100
+15,493
| +114% | +$92.8K |
|
954
Franco-Nevada
FNV
$45.9B
| $389K | ﹤0.01% |
5,948
-988
| -14% | -$73.3K |
|
955
First Industrial Realty Trust
FR
$8.32B
| $389K | ﹤0.01% |
12,000
+2,100
| +21% | +$69.1K |
|
956
Churchill Downs
CHDN
$6.06B
| $386K | ﹤0.01% |
+2,732
| New | +$122K |
|
|
PDLI
957
DELISTED
PDL BioPharma, Inc.
PDLI
| $386K | ﹤0.01% |
161,610
+109,710
| +211% | +$370K |
|
958
Goodyear
GT
$1.75B
| $383K | ﹤0.01% |
15,668
+47
| +0.3% | +$915 |
|
|
NE
959
DELISTED
Noble Corporation
NE
| $378K | ﹤0.01% |
62,000
| – | – |
|
|
MODV
960
DELISTED
ModivCare
MODV
| $377K | ﹤0.01% |
+5,658
| New | +$371K |
|
961
Bloomin' Brands
BLMN
$944M
| $375K | ﹤0.01% |
+19,812
| New | +$394K |
|
962
Caesarstone
CSTE
$87.5M
| $375K | ﹤0.01% |
20,000
-7,000
| -26% | -$110K |
|
|
KAMN
963
DELISTED
Kaman Corp
KAMN
| $370K | ﹤0.01% |
+5,684
| New | +$335K |
|
964
Royal Gold
RGLD
$19.7B
| $367K | ﹤0.01% |
4,808
| – | – |
|
|
ATNX
965
DELISTED
Athenex, Inc. Common Stock
ATNX
| $366K | ﹤0.01% |
1,145
+205
| +22% | +$50K |
|
966
Revvity
RVTY
$12.9B
| $364K | ﹤0.01% |
3,930
+1,700
| +76% | +$153K |
|
967
Semtech
SMTC
$12.7B
| $364K | ﹤0.01% |
6,400
+2,400
| +60% | +$124K |
|
|
BIG
968
DELISTED
Big Lots, Inc.
BIG
| $361K | ﹤0.01% |
+7,539
| New | +$246K |
|
969
Atara Biotherapeutics
ATRA
$75.5M
| $356K | ﹤0.01% |
352
+64
| +22% | +$59.5K |
|
970
Cerus
CERS
$492M
| $352K | ﹤0.01% |
46,000
+8,500
| +23% | +$51.6K |
|
|
DENN
971
DELISTED
Denny's
DENN
| $349K | ﹤0.01% |
+23,142
| New | +$411K |
|
|
SRCL
972
DELISTED
Stericycle Inc
SRCL
| $348K | ﹤0.01% |
5,239
+5,039
| +2,520% | +$228K |
|
973
Amphastar Pharmaceuticals
AMPH
$882M
| $344K | ﹤0.01% |
18,700
+3,300
| +21% | +$73.9K |
|
|
FLXN
974
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $343K | ﹤0.01% |
15,300
+2,800
| +22% | +$37.4K |
|
975
Werner Enterprises
WERN
$2.23B
| $340K | ﹤0.01% |
9,200
+1,100
| +14% | +$36.7K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q1 2019 Portfolio in Review
As of Q1 2019, DekaBank Deutsche Girozentrale held 1,305 positions worth $16.8B, up 11% from $15.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
DekaBank Deutsche Girozentrale withdrew a net $601M in Q1 2019, closing 115 positions and reducing 440 holdings. Its most notable exit was Linde, an estimated $840M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
Against the trend, DekaBank Deutsche Girozentrale opened a new position in Express Scripts Holding Company worth $46.5M.
- DekaBank Deutsche Girozentrale's largest Q1 2019 buy was Express Scripts Holding Company: 521,657 shares worth $46.5M.
- DekaBank Deutsche Girozentrale added most to Johnson & Johnson in Q1 2019, an estimated $101M increase.
- DekaBank Deutsche Girozentrale's biggest Q1 2019 reduction was Procter & Gamble, cutting an estimated $95.7M.
- DekaBank Deutsche Girozentrale fully exited Linde in Q1 2019, selling an estimated $840M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 19% of its $16.8B portfolio in Q1 2019.
- DekaBank Deutsche Girozentrale opened 129 new positions and closed 115 in Q1 2019.
- DekaBank Deutsche Girozentrale's portfolio value rose 11% quarter-over-quarter to $16.8B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2019, filed 10 May 2019.